Arbutus Biopharma Corp·4

Dec 3, 4:02 PM ET

Sofia Michael J. 4

4 · Arbutus Biopharma Corp · Filed Dec 3, 2021

Insider Transaction Report

Form 4
Period: 2021-12-01
Sofia Michael J.
Chief Scientific Officer
Transactions
  • Sale

    Common Shares

    2021-12-01$5.09/sh200,000$1,018,0001,303,403 total
Holdings
  • Common Shares

    (indirect: By Trust)
    167,162
Footnotes (2)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2021.
  • [F2]These shares are owned by the Irrevocable Deeds of Trust of Michael J. Sofia dated July 6, 2020 (the "Trusts"). The reporting person's wife and adult children are both the Trustees and the beneficiaries of the Trusts. The reporting person disclaims beneficial ownership of the shares owned by the Trusts and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Documents

2 files
  • 4
    wf-form4_163856535580377.xmlPrimary

    FORM 4

  • EX-24

    POA - SOFIA